<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00911872</url>
  </required_header>
  <id_info>
    <org_study_id>E-ART</org_study_id>
    <nct_id>NCT00911872</nct_id>
  </id_info>
  <brief_title>EVOLENCE® Assessment of Recovery Time and Impact of Dermal Filler Selection: The E-ART™ Study</brief_title>
  <official_title>EVOLENCE® Assessment of Recovery Time and Impact of Dermal Filler Selection: The E-ART™ Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Solish, Nowell, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Solish, Nowell, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gather information about the immediate effects and recovery
      time for treatment with EVOLENCE/EVOLENCE BREEZE for soft tissue augmentation. The time it
      takes for patients to feel comfortable with the results, and return to their normal daily
      routine is also of important interest
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this Investigator Initiated Study is to document recovery
      time/return to daily activities following facial soft-tissue augmentation with an EVOLENCE
      dermal filler. In addition, the immediate effects such as swelling, bleeding, bruising will
      be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Is to document recovery time/return to daily activities following facial soft-tissue augmentation with an EVOLENCE dermal filler</measure>
    <time_frame>7 Days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the immediate effects such as swelling, bleeding, bruising will be assessed</measure>
    <time_frame>7 Days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>aging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>collagen (EVOLENCE)</intervention_name>
    <description>injectable collagen</description>
    <arm_group_label>aging</arm_group_label>
    <other_name>EVOLENCE and EVOLENCE BREEZE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female &gt; 18 years of age

          -  Need for soft tissue augmentation as evidenced by any of the following:

               -  Bilateral-aging defects &gt; 1 on the Modified Fitzpatrick Wrinkle Scale

               -  Decrease in soft tissue volume in other areas of the face

        Exclusion Criteria:

          -  History of positive hypersensitivity to porcine collagen-based products History of
             multiple food, drug, and substance allergies Autoimmune or collagen vascular disease
             Facial tissue augmentation within 6 months (HA) or 12 months Evolence/Evolence Breeze
             Botulinum-toxin A within 6 weeks Ablative laser treatments within 12 months Permanent
             facial implants Investigational product use within 30 days Pregnant and/or nursing
             woman or woman who plan to become pregnant during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nowell Solish, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private Practice</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nowell Solish Private Practice</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2009</study_first_submitted>
  <study_first_submitted_qc>June 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2009</study_first_posted>
  <last_update_submitted>June 1, 2009</last_update_submitted>
  <last_update_submitted_qc>June 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Nowell Solish</name_title>
    <organization>Private Practice</organization>
  </responsible_party>
  <keyword>wrinkles</keyword>
  <keyword>dermal filler</keyword>
  <keyword>collagen</keyword>
  <keyword>soft tissue augmentation</keyword>
  <keyword>aesthetic</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

